Keyphrases
Reactive Oxygen Species
100%
Signaling Pathway
100%
NADPH Oxidase
100%
Atypical Antipsychotics
100%
Peroxisome Proliferator-activated Receptor
100%
Cholesterol Metabolism
100%
Cluster of Differentiation 36 (CD36)
100%
Macrophage Foam Cells
100%
Olanzapine
50%
Detrimental Effects
33%
Macrophages
33%
Oxidized Low-density Lipoprotein (ox-LDL)
33%
Genomic Deletion
33%
Clozapine
33%
CD36 Expression
33%
Apolipoprotein E-deficient
33%
Reactive Oxygen Species Production
16%
Receptor Activity
16%
Schizophrenic Patients
16%
In Vitro Study
16%
Pharmacological Inhibitors
16%
Drug-induced
16%
SiRNA Knockdown
16%
Clinical Reports
16%
Apolipoprotein E Knockout Mice
16%
CD36 Gene
16%
NADPH Oxidase Activity
16%
Macrophage Foam Cell Formation
16%
Hyperlipidemic Rats
16%
Neuroscience
Macrophage
100%
Cell Signaling
100%
Reactive Oxygen Species
100%
Atypical Antipsychotic
100%
Metabolic Pathway
100%
Peroxisome Proliferator-Activated Receptor
100%
Typical Antipsychotic
100%
Foam Cell
100%
CD36
100%
NADPH Oxidase
100%
Apolipoprotein E
37%
Olanzapine
37%
Gene Deletion
25%
Clozapine
25%
In Vivo
12%
In Vitro
12%
Small Interfering RNA
12%
Pharmacology, Toxicology and Pharmaceutical Science
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase
100%
Reactive Oxygen Metabolite
100%
Peroxisome Proliferator Activated Receptor
100%
Atypical Antipsychotics
100%
Atherosclerosis
66%
Olanzapine
50%
Apolipoprotein E
50%
Clozapine
33%
Disease
16%
Small Interfering RNA
16%
Hyperlipidemia
16%
Atherogenesis
16%